Clinical curative efficacy of inducing remission for the newly diagnosed aged AML patients by chemotherapy with IA and DA regimens

• Published in: Zhongguo shi yan xue ye xue za zhi Vol. 22; no. 5; p. 1282
• Main Authors: Tian, Dong-Hua, Gan, Si-Lin, Xing, Hai-Zhou, Liu, Yan-Fang, Xie, Xin-Sheng, Sun, Hui
• Format: Journal Article
• Language: Chinese
• Published: China 01.10.2014
• Subjects: Aged; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Cytarabine - administration & dosage; Female; Humans; Idarubicin - administration & dosage; Induction Chemotherapy; Leukemia, Myeloid, Acute - drug therapy; Male; Middle Aged; Retrospective Studies

This study was aimed to explore the clinical efficacy and toxicity of idarubicin (IA regimen) and daunoru-bicin combined with cytarabine (DA regimen) for treating aged patients with AML as induction chemotherapy. The clinical data of 60 newly diagnosed AML aged patients treated with IA or DA regimen...